ERIKA GROSS: Open Payments
NPI 1013389923 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 20 payments from 13 companies in 2025. Trend: 2023 $929 · 2024 $1,380 · 2025 $1,699
Food & beverage: $1,468Education: $231
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $327 |
| Incyte Corporation | 3 | $219 |
| Novartis Pharmaceuticals Corporation | 3 | $151 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| Gilead Sciences, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $125 |
| Amgen Inc. | 1 | $117 |
| Merck Sharp & Dohme LLC | 1 | $113 |
| Tempus AI, Inc | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $94 |
Products named: RYBREVANT, SARCLISA, Jakafi, KISQALI, Trodelvy, Vyloy, IMFINZI, IMDELLTRA (AMG757).
Industry payments across OH — which companies pay providers there.
